EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study

Alaa Talal Qumsani iD

Biology · 19.06.2025 · 14 (6) · 723

DOI: 10.3390/biology14060723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology, online erschienen am 19.06.2025. Verfasst von Alaa Talal Qumsani. Beteiligte Einrichtung: Biology Department, Al-Jumum University College, Umm Al-Qura University, Makkah 24382, Saudi Arabia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota has emerged as a critical modulator in metabolic diseases, with substantial evidence supporting its role in attenuating diabetes-related nephropathy. Recent investigations demonstrate that strategic manipulation of intestinal microflora offers novel therapeutic avenues for safeguarding renal function against diabetic complications. This investigation sought to determine the nephroprotective potential of Lactobacillus rhamnosus GG (LGG) administration in diabetic nephropathy models. Six experimental cohorts were evaluated: control, probiotic-supplemented control, diabetic, diabetic receiving probiotic therapy, diabetic with antibiotics, and diabetic treated with both antibiotics and probiotics. Diabetic conditions were established via intraperitoneal administration of streptozotocin (50 mg/kg) following overnight fasting, according to validated protocols for experimental diabetes induction. Probiotic therapy (3 × 109 CFU/kg, bi-daily) began one month before diabetes induction and continued throughout the study duration. Glycemic indices were monitored at bi-weekly intervals, inflammatory biomarkers, renal function indices, and urinary albumin excretion. The metabolic profile was evaluated through the determination of HOMA-IR and the computation of metabolic syndrome scores. Microbiome characterization employed 16S rRNA gene sequencing alongside metagenomic shotgun sequencing for comprehensive microbial community mapping. L. rhamnosus GG supplementation substantially augmented microbiome richness and evenness metrics. Principal component analysis revealed distinct clustering of microbial populations between treatment groups. The Prevotella/Bacteroides ratio, an emerging marker of metabolic dysfunction, normalized following probiotic intervention in diabetic subjects.

Results

L. rhamnosus GG administration markedly attenuated diabetic progression, achieving glycated hemoglobin reduction of 32% compared to untreated controls. Pro-inflammatory cytokine levels (IL-6, TNF-α) decreased significantly, while anti-inflammatory mediators (IL-10, TGF-β) exhibited enhanced expression. The renal morphometric analysis demonstrated preservation of glomerular architecture and reduced interstitial fibrosis. Additionally, transmission electron microscopy confirmed the maintenance of podocyte foot process integrity in probiotic-treated groups.

Conclusions

The administration of Lactobacillus rhamnosus GG demonstrated profound renoprotective efficacy through multifaceted mechanisms, including microbiome reconstitution, metabolic amelioration, and inflammation modulation. Therapeutic effects suggest the potential of a combined probiotic and pharmacological approach to attenuate diabetic-induced renal pathology with enhanced efficacy.

Schlagwörter

Stichwörter der Autor:innen

Lactobacillus rhamnosus GGdiabetic nephropathy preventiongut–kidney crosstalkinflammatory regulationmetabolic modulationmicrobiome engineeringreno protective mechanisms

Autor:innen und Institutionen

  • Biology Department, Al-Jumum University College, Umm Al-Qura University, Makkah 24382, Saudi Arabia.

ORCID-Profile: Alaa Talal Qumsani

Zitieren

APA

Qumsani, A. T. (2025). Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study. Biology, 14(6), 723. https://doi.org/10.3390/biology14060723

Vancouver

Qumsani AT. Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study. Biology. 2025;14(6):723. doi:10.3390/biology14060723

BibTeX
@article{Qumsani2025,
  author = {Qumsani, Alaa Talal},
  title = {Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study},
  journal = {Biology},
  year = {2025},
  volume = {14},
  number = {6},
  pages = {723},
  doi = {10.3390/biology14060723}
}
Kostenlos starten →